Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Acquisition of MSS Management Systems Services Ltd

3 Jul 2013 07:00

RNS Number : 4492I
Ideagen PLC
03 July 2013
 



 

Ideagen plc

("Ideagen" or the "Company")

 

Acquisition of MSS Management Systems Services Ltd

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions, is pleased to announce that it has acquired MSS Management Systems Services Ltd, (MSS) a leading supplier of Emergency and unscheduled software care solutions to the NHS.

 

Acquisition Rationale

MSS is the developer and owner of 'Patient First', an Information Management Solution which supports the everyday practices of NHS Accident & Emergency (A&E) departments. Patient First provides the end user with an intuitive application that delivers real-time clinical management of patients in the acute and minor injuries environment whilst supporting the delivery of the complex information needs of NHS Trusts.

 

There is a growing need to improve data collection and clinical processes within A&E departments to support KPIs and national quality standards. Patient First will be integrated into Ideagen's existing E-Casenote and Order Communications solutions to provide a robust and scalable platform with access to real time information showing where a patient is and future requirements for the A&E department and NHS Trust.

 

Patient First supports some of the largest A&E departments across the country and manages approximately 1.8 million attendances in A&E departments per annum across 10 Acute Trusts in England. For the 12 month period ended 31 March 2013, MSS generated revenues of approximately £500k with recurring maintenance revenues of approximately £300k and earnings before interest and tax of £144k. MSS had net assets of approximately £150k as at 31 March 2013. Cash at completion was approximately £176k.

 

Financial Terms of the acquisition

The initial net cash consideration for the acquisition of MSS is £589k with a further £50k deferred for 12 months. Additionally, up to a further £540k cash may be payable on certain revenue targets being achieved in the period to 30 April 2014. The maximum amount would be payable on revenues achieved in the 10 month period to 30 April 2014 of £1.5m. The acquisition will be funded from Ideagen's cash resources and will be immediately earnings enhancing.

 

David Hornsby Chief Executive said: "With total attendances at hospital A&E units in England having risen every year for the past eight years, medical organisations have voiced concern about what they believe is an unsustainable rise in attendances and admissions. Ideagen has identified that emergency care services need more robust systems to manage this increased workload. Patient First, together with our existing NHS Information Management software, will enable us to help deliver the transformation required."

 

Enquiries:

Ideagen Plc

Tel: 01629 699100

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Matt Goode (Corporate Finance)

Charlotte Stranner

Ben Thompson

Stephen Norcross (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780

Helen Westaway

Helen.westaway@walbrookpr.com

Paul Cornelius

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUURNRORABRAR
Date   Source Headline
8th Jul 20227:00 amRNSCancellation - Ideagen Plc
8th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
7th Jul 20223:45 pmRNSHolding(s) in Company
7th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
7th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
7th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
7th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
7th Jul 20221:19 pmGNWForm 8.3 - Ideagen PLC
7th Jul 202211:21 amRNSForm 8.3 - Ideagen plc
7th Jul 202210:39 amRNSForm 8.5 (EPT/RI)
7th Jul 20229:08 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
7th Jul 20227:30 amRNSSuspension – Ideagen PLC
7th Jul 20227:00 amRNSHolding(s) in Company
7th Jul 20227:00 amRNSScheme becomes Effective
6th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
6th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
6th Jul 20223:10 pmRNSHolding(s) in Company
6th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
6th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
6th Jul 202211:41 amRNSForm 8.5 (EPT/RI)
6th Jul 202211:08 amGNWForm 8.3 - [IDEAGEN PLC - 05 07 2022] - (CGWL)
6th Jul 202211:03 amRNSForm 8.3 - IDEAGEN PLC
6th Jul 20229:09 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
5th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
5th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
5th Jul 20222:30 pmRNSExercise of Options, Issue of Equity and Rule 2.9
5th Jul 20222:20 pmRNSCourt Sanction of Scheme of Arrangement
5th Jul 202212:24 pmGNWForm 8.3 - [IDEAGEN PLC 04 07 2022] - (CGWL)
5th Jul 202212:13 pmRNSDisclosure under Rule 26
5th Jul 202212:10 pmRNSForm 8.3 - Ideagen plc
5th Jul 202210:58 amRNSForm 8.5 (EPT/RI)
5th Jul 20228:13 amRNSForm 8.5 (EPT/RI)
4th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
4th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
4th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
4th Jul 20222:30 pmRNSHolding(s) in Company
4th Jul 202212:07 pmRNSForm 8.3 - Ideagen plc
4th Jul 202210:55 amRNSForm 8.5 (EPT/RI)
4th Jul 202210:47 amGNWForm 8.3 - [IDEAGEN PLC - 01 07 2022] - (CGWL)
4th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
1st Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
1st Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:11 pmGNWForm 8.3 - [Ideagen plc - 30 06 2022] - (CGWL)
1st Jul 20223:09 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
1st Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
1st Jul 202212:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.